Welcome to Our Treatment Page
Last Modified Monday, September 01, 2008
     Please Scroll Down  
  
 
   
  Start Here   Meniere's Disease Information   Site Information  
  What is Meniere's Disease?
What is the cause of it?
What is the cure for it?
What can I do about it?
More
...
  Home
What's New
Our Q&A Blog
Our Forums
Glossary
Find Doctors

Symptoms
Cause
Diagnosis
Treatment
Prognosis
Research
Disability

Meniere's Book
Meniere's DVDs
 
Famous Patients
Calendar
Serc
Hearing Technology
Travel by Air & Sea

Sudden Hearing Loss
Donate to Research
  About Us
Disclaimer
Mission
Copyright
Ownership
Funding
Privacy
Report Errors
Media Inquiries
Email Us
Ask Questions
Site Map
More...
 
 

 <-- Search This Site      Meniere's DVD Videos    Ask Questions    Recent Research    Recent News    Our Blog   

 
 

Click On These Icons to Link to Specific Topics

 
     
     


Meniere's Disease Treatment
Copyright © 1997-2008 Meniere's Disease Information Center.  All rights are reserved.
All copying, including (but not limited to) websites, bulletin boards, forums, and blogs, is prohibited.
Click here for more copyright information.

If "it" helps you, "it" helps you, no matter what "it" is.
That doesn't mean that "it" will help anyone else.

Meniere's Disease Treatment
Table of Contents

Treatments Are and Always Have Been Listed Here in Rough Order Of Least Invasive, Least Costly, Increasing to Most Invasive, Most Costly.

  •  There is no cure. 
    • There is no known cause of Meniere's Disease, there is no known cure for Meniere's Disease, and there is no cure on the horizon.  That's not "negative thinking"; that's simply the fact of the matter and there is no point in denying it or offering false or gratuitous hope.  Click here to see the latest research.  The good news is that Meniere's Disease is not fatal, that there are many possible "symptomatic" treatments (treatments for the symptoms) with which patients can try to lessen or at least manage their symptoms, and that some patients experience temporary spontaneous remissions of varying periods of time.  However, some patients are unresponsive to virtually all treatments, including invasive surgery, and will become disabled.  See this and other pages of this website for further information.
  • Treatment in brief.
    • Most, but not all, treatments are for symptoms believed to be caused by excess endolymphatic fluid.  Unless otherwise indicated, the treatments described below appear to be founded on the theory that Meniere's Disease symptoms result from excess endolymphatic fluid in the inner ear ("idiopathic endolymphatic hydrops.") While this is the prevailing theory, it is not the definitive theory.
    • Strategies for obtaining treatment.
      • Sometimes patients are confounded in their quest for treatment because there is no qualified doctor in their town.  The solution to this problem is simple:  go out of town.
        • Visit our doctors page for strategies on obtaining a treatment plan from an out-of-town specialist who coordinates treatment with your local doctor.
  • Which treatments work.
    • No one treatment works for everyone, yet every treatment seems to work for someone.  We each seem to respond differently to various treatments.  Some patients are nearly symptom-free just by observing a low-sodium diet (see below). Other patients may need more complex and/or more invasive treatment.  Other patients seem unresponsive to any treatment -- even invasive surgery.
    • The bottom line:  each patient tries to find the treatment (or treatments) that works best for each one of us.
    • Our lay and inexpert speculation: perhaps there are ten (or more or fewer) currently unknown diseases that each have the same symptoms as what we now call "Meniere's Disease," and we each have one (or perhaps two or three) of the ten (or more or fewer) of the currently unknown diseases. *IF* this is true, then ten patients could be diagnosed with "Meniere's Disease," yet each one could have a different disease, and each one could respond differently to various treatments.
  • Note on temporary spontaneous remission.    While not a "treatment," some patients experience temporary unexpected ("spontaneous") remission (cessation or reduction in symptoms) lasting days, weeks, months, or even years.  There is no way to determine who will, or who won't, experience temporary spontaneous remissions, and there is no way to determine how long a temporary spontaneous remission might last.
  • Treatment though clinical trials.
    • What is a clinical trial?  U.S. National Institutes of Health.
    • The U.S. government has a website for information on clinical trials:  www.clinicaltrials.gov.
      • These clinical trials are usually conducted by the NIH (National Institutes of Health).  In the usual clinical trials, there are two groups, the test group and the control group.  The test group is treated in some way.  The control group is "pretend-treated," usually with a placebo ("fake") drug.  Studies may last one year, more or less.  The results of both groups are compared to see whether patients in the test group improved significantly compared to the control group.  You might or might not like to participate in a study.  Remember, one group  will always be given placebo ("fake") treatment.  However, control groups are necessary in research and patients in the control group make very useful contributions to medical science.  If you are interested in participating in a clinical trial, talk to your doctor.
    • The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has a website for searching for clinical trials:  www.ifpma.org/clinicaltrials.html
      • This website searches the U.S. NIH site, http://www.clinicaltrials.gov, and in addition searches other information sources at the same time, providing all the results together.
  • Treatment with dietary and lifestyle adjustments.
    • Purpose.  The purpose of dietary and lifestyle modification therapies is to reduce all symptoms by reducing conditions that may initiate or exacerbate (worsen) symptoms.
    • Sodium (salt) avoidance.
      • Physicians frequently prescribe a low-salt diet to reduce the amount of sodium in the body.  
        • Sodium in the body increases fluid retention.  Common table salt is, of course, sodium chloride, and is normally the primary source of sodium in the body.  On the theory that Meniere's Disease symptoms may result from excess endolymphatic fluid in the inner ear, physicians often counsel patients to reduce overall fluid in the body, with the hope that endolymphatic fluid will be reduced in the process.  To reduce sodium intake and, therefore, reduce bodily fluids, physicians often counsel a low-salt diet and, in addition, prescribe diuretics to further reduce the bodily fluids. 
      • Results vary.
        • Some patients anecdotally report a strong correlation between salt ingestion and onset or worsening of symptoms. Other patients anecdotally report no correlation between salt and symptoms at all.
      • What's a low-sodium (low-salt diet)?
        • Descriptions vary. Some say the less the better. Some degree of sodium intake is necessary to stay healthy. Many patients attempt to keep their sodium intake under 1,000 mg. per day. A few say that they succeed.  Ask your doctor how much sodium is right for you.
      • Low sodium websites.
        • LivingLowSodium.com.  One of the proprietors has Meniere's Disease (as stated here).  Books, snacks, soups, sauces, salad dressings, and more.  Friendly, artistic site design.
        • Saltwatcher.com.  Online resource with low-sodium information and recipes; also has food products for sale online.
        • Low Sodium Cooking Great site!  Quote:  "A can of chili may contain 2400 mg [of salt] all by itself; homemade chili may contain less than 100 mg."  Need we say more?
        • Salt Free Life. Terrific low-cost membership website! You don't have to do low salt to love the recipes, reviews, and cooking tips. Non-members get a free recipe every month. Members may access an archive of over 240 recipes with new recipes posted every month. Now your family will love and share the low- and no-salt meals that you have to have. You can have dinner guests again without guilt! (No, we do NOT get paid to say this!)
        • Dr. Salt's Salt Page (Washington University). Alec Salt, Ph.D., is the author of this page on, ironically, salt; it is addressed specifically to Meniere's Disease patients.
      • Low sodium books.
    • Alcohol avoidance.
      • Some patients report that alcohol intake is devastating. Others report no effects whatsoever on their Meniere's Disease symptoms after imbibing.
    • Caffeine avoidance.
      • Many patients report that caffeine intake is devastating. Some patients report that caffeine has no effect whatsoever on their Meniere's Disease symptoms.
    • Nicotine avoidance.
      • Physicians nearly always prescribe cessation of smoking, and many Meniere's Disease patients -- who can -- quit out of necessity.
    • Stress avoidance.
      • Stress is suspected to have a role in Meniere's Disease, although stress is not well suited for objective measurement and is not well documented.
    • Trigger avoidance and treatment. 
      • While the cause of Meniere's Disease is unknown, there are "triggers" that can (for known or unknown reasons) initiate or exacerbate (worsen) symptoms in *some* patients.  Most patients find it helpful to identify and avoid -- or treat -- triggers, when possible, thereby indirectly treating the symptoms of Meniere's Disease.
      • Triggers known to affect many (but not all) patients.
        • Allergies, including food allergies.
          • Allergies, including food allergies, are believed by many to have a role in triggering Meniere's Disease symptoms in *some* patients.  Treatment of allergies may or may not help reduce Meniere's symptoms or frequency of occurrences, depending upon the patient.
          • Some patients seek allergy testing in order to see whether avoidance of allergenic reactions may help to reduce the frequency and/or intensity of Meniere's Disease episodes.  Anecdotally, this strategy seems to help some patients, but not all patients.
          • Dr. Jennifer Derebery, House Ear Institute, Los Angeles, studies the relationship of allergies to Meniere's Disease.
          • Click here to search PubMed for Meniere's Disease and allergy research by Dr. Jennifer Derebery.
        • Menstruation.
          • Some women patients experience Meniere's symptoms in conjunction with menstruation.
          • Washington University.
            • Dr. Gwen Morse and Dr. John House have authored a paper describing evidence of a  relationship between the menstrual cycle and Meniere's Disease responses in some women.  "Results from this study provide evidence that a unique relationship does exist between the menstrual cycle and Meniere's disease responses for some women. Knowledge gained from this study is beneficial in identifying the importance of appropriate clinical assessment methods of menstruate women with Meniere's disease. Recommendations include further research with larger samples and testing of different symptom management strategies for women of different perimenstrual symptom patterns."
        • Pregnancy.
          • Some women patients anecdotally report that their symptoms are exacerbated during pregnancy.
          • Some women patients report that their symptoms of Meniere's Disease first appeared either during pregnancy or soon after delivery.
        • Visual stimuli.  
          • Some patients anecdotally report that certain visual events, especially parallel vertical lines, will trigger dizziness and other symptoms. Here are some examples:
          • Streets and highways lined with trees or telephone poles.
          • Supermarket aisles.
          • Some motion pictures.
        • Barometric pressure.
          • Some patients anecdotally report that changes in barometric pressure can trigger symptoms.  Some patients so affected track weather patterns very closely in an attempt to anticipate increases in symptoms.
        • Other triggers.
          • There are literally a million possible triggers, because each patient is different.  The patient's objective is to identify condition that may be triggers for that patient.
  • Treatment with complementary and alternative medicine (CAM).
    • Homeopathy.
      • Cautions.
      • Vertigoheel.
        • Vertigoheel is a homeopathic product manufactured by Heel.
        • Study Published in AMA Professional Journal Implies Efficacy of Vertigoheel and Betahistine Hydrochloride (Serc).  The bottom line: "Results: Both homeopathic [Vertigoheel] and conventional [betahistine hydrochloride (often referred to by the brand name "Serc")] treatments showed a clinically relevant reduction in the mean frequency, duration, and intensity of the vertigo attacks. The therapeutic equivalence of the homeopathic remedy [Vertigoheel] and betahistine [hydrochloride ("Serc")] was established statistically."
          • Comment: This study equates the efficacy of Vertigoheel with the efficacy of Serc (betahistine hydrochloride), but the efficacy of Serc is itself controversial.  See our page on Serc.
        • Click here to search PubMed for Meniere's Disease and Vertigoheel.
        • Update January 17, 2007: 
          • We previously believed and reported that Vertigoheel had been approved by the FDA for the treatment of vertigo on the basis of the above study, that Vertigoheel was thus available in the U.S. by prescription only, and that Vertigoheel was listed as a prescription drug in the Physicians' Desk Reference (PDR) (possibly in the 1998 edition and possibly on page 1187 of that edition).
          • However, today we are unable to confirm through authoritative sources that Vertigoheel is currently approved by the U.S. FDA in any respect, that it ever was approved by the FDA in any respect, or that a prescription is or ever has been required for the purchase of Vertigoheel.  Today, there was virtually no information about Vertigoheel at the FDA website.  Click here to search the FDA website for yourself.  Vertigoheel is not listed in the 2007 PDR (Physicians' Desk Reference).
          • We found that Vertigoheel made by Heel is available without a prescription from this source. We found that a similar product, cocculus compositum, made by Heel, is available without a prescription from the same sourceNote:  This is news, not advertising, and we receive no compensation for posting this information.
        • We received this email on October 15, 2002:  "I receive so many phone calls from people with Meniere's who have been looking for Vertigoheel to help treat their symptoms and who have had a lot of  trouble finding the product -- anywhere -- that I thought I would write and let you know that I sell Cocculus Compositum (exact formula as Vertigoheel but you don't need a prescription) for $18.06 (20% off) and usually ship the next day by priority mail. [Note that the manufacturer of this product is Heel, the company that also manufactures Vertigoheel. -- Editor.]  My website is Vitamin-Resource at http://www.vitamin-resource.com, and there is a direct link to the Cocculus Compositum tablets [here].  Hope this will be helpful to some of your members.  Best wishes, Joanne Lindon, Vitamin-Resource."  Note:  This is news, not advertising, and we receive no compensation for posting this information.
      • Ventigoheel.
    • Chiropractic.
    • Osteopathy.
      • Cautions.
      • Symptomatic relief after treatment of temporomandibular disorder (TMD) and cervical spine disorders (CSD) in patients with Meniere's disease: a three-year follow-up.  Abstract at PubMedAccording to the abstract, results showed that a coordinated treatment of TMD and CSD in patients with Meniere's disease is an effective therapy for symptoms of this disease. The results suggested that Meniere's disease has a clear association with TMD and CSD and that these three ailments appeared to be caused by the same stress, nervousness, and muscular tension.
  • Treatment with devices.
  • Treatment with vestibular rehabilitation therapy (VRT).
  • Treatment with medicine.
    • It is always prudent to thoroughly research the effects and drug interactions of any medication that you contemplate taking. Talk to your pharmacist and to your physician.
    • Overview.
    • Diuretics.
      • Diuretics are often prescribed to treat Meniere's Disease, often in conjunction with a low-salt diet (see above), apparently for the purpose of reducing body fluids in general and endolymph in particular.  This treatment presumes that the patient suffers from (idiopathic) endolymphatic hydrops (excess endolymphatic fluid).
      • For unknown reasons, a patient's Meniere's Disease symptoms may not be responsive to one diuretic drug yet may be very responsive to another diuretic drug.  Thus, one should discuss with one's doctor trying at least two different diuretics before concluding that "diuretics don't work for me."
      • Notes from the University of Kansas (KU) Medical Center; scroll down to "treatment."
      • Maxzide (sometimes spelled (perhaps incorrectly) Maxide); Dyazide (generic: triamterene/hydrochlorothiazide (HCTZ)).
      • Diamox (generic:  acetazolamide).
      • Neptazane (generic:  methazolamide).  Somewhat less commonly, Neptazane, which is often prescribed to treat glaucoma, is prescribed to treat Meniere's Disease.  Washington University (St. Louis) Physicians; Emedicine.com.
      • Isosorbide. 
        • An osmotic diuretic named "isosorbide" is used to treat Meniere's Disease in Japan, according to this study.  (Note:  There is an "isosorbide" (isosorbide dinitrate), a vasodilator, that is used to treat angina pectoris (chest pain due to heart disease) in the U.S.  The two are NOT the same.)  Studies of treatment of Meniere's Disease in Japan with isosorbide date back more than 20 years.  Whether there any reason to think that the osmotic diuretic isosorbide would be any more effective than the diuretics triamterene/HCTZ (Maxzide, Diazide) or acetazolamide (Diamox) that are commonly prescribed in the U.S. is hard to say.  Some people seem to do better on triamterene/HCTZ than acetazolomide, and vice versa.  Perhaps some people would do better on isosorbide and perhaps not.  Like all things Meniere's, nothing is certain.   
    • Antiviral drugs.
      • We are hearing anecdotal reports from patients who are (perhaps by their own demand) being treated with antiviral drugs such as acyclovir (Zovirax), famciclovir (Famvir), and valacyclovir (Valtrex) -- with mixed results.  This apparently responds to a few studies finding a tenuous (in our view) connection between the herpes simplex virus (HSV) and Meniere's Disease.  (Read more at the herpes simplex virus section of our Cause Page.)  No study in PubMed states for a fact that HSV is a cause of Meniere's Disease.  There are almost no studies to be found at PubMed on the subject of treating Meniere's Disease with acyclovir or other antiviral drugs and none that finds that an antiviral drug is effective in treating vertigo caused by Meniere's Disease (for example, this study by Dr. Derebery, et al., of the House Ear Clinic in Los Angeles).
      •  "Effectiveness of Acyclovir on Meniere's Syndrome III Observation of Clinical Symptoms in 301 cases," Mitsuo Shichinohe, M.D., Ph.D., The Sapporo Medical Journal, Vol. 68, No. 4-6, December, 1999.  
        • The full text of this paper is available in English at Dr. Shichinohe's website here in eight separate download files (one download file for each of eight pages) in .pdf format.
        • MenieresInfo.com report, revised April 13, 2007.
          • This study is not listed in PubMedThe Sapporo Medical Journal is published by Sapporo Medical University, Sapporo Japan.  The "III" in the title means that this is the third paper in a series of three authored by Dr. Shichinohe, none of which appears in PubMedThe other two papers are cited in footnotes 1 and 2 of this study.  As of January 8, 2007, Dr. Shichinohe is listed as author or co-author of five articles in PubMed (click here).
          • Results:  In this study, patients were each treated with 2,000 mg/day of acyclovir for an average period of two weeks. There were 250 patients who were ultimately evaluated.  In 82.5% of cases diagnosed as Meniere's Disease, 85% of cases diagnosed as Meniere's Syndrome (symptoms of Meniere's Disease but other basic diseases could not be completely excluded), and 89.1% of cases diagnosed as vestibular dysfunction, vertigo disappeared, and tinnitus and hearing were improved.  No side effects were observed.
          • Limitations: This study was not randomized, not double-blind, not blind, and not controlled.  As stated in the study, patients "knew" of the effectiveness of acyclovir and "wished" the treatment. We have not found any subsequent citations to this study in PubMed.  We have found no replication of this study. A randomized, double-blind, placebo-controlled clinical trial of the antiviral drug famciclovir (Famvir) for reduction of Meniere's disease symptoms by Dr. Derebery, et al., of the House Ear Clinic in Los Angeles, reported in 2004, found no "dramatic" effects on "vertigo or dizziness" and that famciclovir simply "may" suppress the fluctuation of hearing.
          • Comment:  Despite the limitations of Dr. Shichinohe's study, the results are impressive.  While a viral etiology (cause) of Meniere's Disease has not been positively established, there are researchers who suspect, even in the absence of persuasive evidence, that a virus, and particularly the herpes simplex virus (HSV), *may* be a factor in *some* cases diagnosed as Meniere's Disease.  We believe that it can be worthwhile for patients to discuss this study with their doctors, together with other relevant studies. 
      • Click here to search PubMed for Meniere's Disease and (herpes or (acyclovir and other antiviral drugs)).
      • Click here to search PubMed for Meniere's Disease and acyclovir and other antiviral drugs.
      • Click here to search PubMed for Meniere's Disease and herpes.
    • Vestibular sedatives.
      • These drugs are intended to sedate the vestibular system to reduces the effects of vertigo (the spinning sensation).  Not surprisingly, these "vestibular sedatives" can have a side effect of drowsiness.  Yet, some patients complain that the vestibular sedatives make them drowsy.  Such is the nature of medicine:  one trades off the benefit of the treatment in exchange for acceptance of the side effects.  In this case, one makes a choice as to whether one would prefer vertigo or drowsiness.  However, what many patients fail to understand is that they can work with their doctors to adjust the dosage of the vestibular sedatives to reach the point at which the patient is willing to accept the trade-off:  the point at which the vertigo is sufficiently controlled and at which the patient is willing to accept that particular degree of drowsiness as a side effect.  One's doctor may either adjust the strength of the prescription or simply advise the patient to break or cut the pills.
      • Valium (generic: diazepam).
        • The purpose of Valium in treating Meniere's Disease is to prevent or reduce vertigo by sedating the vestibular system.
      • Antivert, Meclizine (generic: meclizine hydrochloride). 
        •  Antivert (Meclizine) is an antihistamine that is also a vestibular sedative.  The purpose of Antivert in treating Meniere's Disease is to prevent or reduce vertigo and hence the resultant nausea by sedating the vestibular system.
        • Information on meclizine hydrochloride is available at MedLinePlus (NIH).
        • Meclizine hydrochloride 25 mg. tablets may be purchased over-the-counter in the U.S. and elsewhere under various brand name and private label products sold for car, air, and seasickness, including Dramamine II and Dramamine Less Drowsy Formula, Bonamine, and Bonine (but not regular Dramamine, which is 50 mg. dimenhydrinate)Names and formulations vary and are subject to change; be sure to read the ingredients and potency listed on the package.
        • Also available in generic form, over the counter (but sometimes "behind the counter," meaning one asks the pharmacist for it but a prescription is not required).
        • Generic meclizine hydrochloride can be bought by mail without prescription at Amazon.com and elsewhere.
      • Phenergan (promethazine hydrochloride).  
        • Phenergan is an antihistamine and vestibular sedative, the purpose of which in treating Meniere's Disease is to sedate the vestibular system. Those who are currently experiencing nausea and vomiting and are unable to "keep down" the oral form may well find that rectal suppositories of this drug are much more effective.
        •   May be prepared in a topical (tube) form for application to the skin (for absorption through the skin) by a pharmacy if so ordered by a prescription, but not all doctors and pharmacists are aware of this.
      • Stugeron, (cinnarizine) (not available in the U.S.). 
        • Stugeron is an antihistamine that is also a vestibular sedative.  The purpose of Stugeron in treating Meniere's Disease is to prevent or reduce vertigo and hence the resultant nausea by sedating the vestibular system.  Stugeron is commonly prescribed in the U.K. and is not available in the U.S.
    • Anti-nausea drugs.
      • Unlike some diseases and conditions, and some drugs, Meniere's Disease does not cause nausea.  Meniere's Disease causes vertigo (the spinning sensation), a consequence of which may be nausea.  A consequence of the nausea may be vomiting -- sometimes severe, even projectile, vomiting.  Ideally, one would control one's nausea by controlling one's vertigo.  However, when attempts at controlling one's vertigo are ineffective, then one will still want to try to control the consequential nausea.  One of the problems with taking medicine to control nausea is that if one is already vomiting, one will have difficulty in keeping down and absorbing oral meds.
      • Scopolamine transdermal patch.
        • This patch was off the U.S. market for some time, but it's back. Scopolamine is sometimes prescribed as an antiemetic, antinausea drug to treat the nausea of Meniere's Disease brought on by vertigo.
      • Phenergan (promethazine hydrochloride).
        • An antihistamine and vestibular sedative, the purpose of which in treating Meniere's Disease is to sedate the vestibular system. Those who are currently experiencing nausea and vomiting and are unable to "keep down" the oral form may well find that rectal suppositories of this drug are much more effective.
      • Ginger root.
        • Although ginger root is not a "drug," we mention it here because so many people find that ginger root, or ginger root tea, is effective in reducing nausea.
    • Immunosuppressant (immuno-suppressant) drugs. 
      • Immunosuppressant drugs include:  prednisone, methotrexate, Enbrel, Remicade, etc.
      • Treatment of immune-mediated (induced) conditions.  (Also called immune-mediated, autoimmune-mediated, and auto-immune-mediated conditions.) 
      • Prednisone.
        • Prednisone is a generic name for several branded drugs; it is a steroid, the purpose of which in treating Meniere's Disease is to suppress the immune system and/or to reduce inner ear inflammation.  You should be extremely careful in following the prescribed instructions for taking this powerful drug, especially any instructions regarding a tapered withdrawal. Prednisone is often prescribed for Meniere's Disease, sometimes in combination with, or preceding, treatment with methotrextate (MTX) or other powerful immunosuppressant drugs.  Chronic (long-term) administration of prednisone would have extremely serious side effects that should be discussed with your doctor.
        • A doctor who suspects or just wants to confirm or eliminate the possibility of an immune-mediated etiology (cause) may prescribe a round of prednisone, even in the absence of diagnostic tests that indicate an autoimmune etiology. Some patients may not be responsive to a low-dose trial of prednisone yet may inexplicably respond remarkably to a high-dose trial of prednisone.  If the patient's symptoms are reduced by the prednisone, then longer-term immunosuppressant treatment may be recommended.
        • MedicineNet on prednisone.
        • Coping With Prednisone (and Other Cortisone-Related Medicines); It May Work Miracles, but How Do You Handle the Side Effects? by Eugenia Zukerman and Julie R. Ingelfinger, M.D.
      • Methotrexate (MTX).
        • This immunosuppressant drug has been used to treat suspected immune-mediated cochleovestibular disorders. Note that methotrexate should be administered carefully and is reported to have caused deaths. See the article at RXMEDStill, methotrexate is widely prescribed for autoimmune diseases, especially rheumatoid arthritis.  Sometimes otologists will prescribe a therapy of methotrexate to be administered by a rheumatologist who has more experience with immunosuppressant drugs.
      • Emerging immunosuppressant drugs.
        • There are emerging immunosuppressant drugs, such as Enbrel and Remicade, that are finding their way into treatment of suspected immune-mediated Meniere's Disease.  Talk to your doctor.
    • Serc (betahistine hydrochloride). 
      • This drug which is widely prescribed for Meniere's Disease outside of the U.S. Contrary to false information available elsewhere, this drug under the brand name Serc may be imported under strict conditions into the U.S., and the generic equivalent (betahistine hydrochloride) is legally available by prescription from compounding pharmacists in the U.S. 
      • See our comprehensive page on Serc (Betahistine Hydrochloride) for more information,
    • Histamine.
    • Lidocaine (also see licodaine under surgical, below).  
      • The purpose of using lidocaine in the treatment of Meniere's Disease is to treat the symptom of tinnitus.  There has been an early report that indicates that lidocaine drops in the nose may help to reduce tinnitus in some patients. This therapy is in its infancy all over again. The potential of the "cains" for relieving tinnitus was first observed long ago.
      • FDA on lidocaine and tinnitus.
      • Retrospective case review on the administration of lidocaine to treat tinnitus by Dr. John J. Shea, Jr., and presented at the American Otological Society Annual Meeting in Orlando, Florida, May 13, 2000.  This paper is not reported in PubMed.
      • Novocain (procaine hydrochloride) was long ago found to have some tinnitus-relieving properties.  Xylocaine (lidocaine hydrochloride) is in current vogue.
      • Click here to search PubMed for lidocaine and tinnitus.
  • Treatment with surgery.
    • Overview.
    • Surgical talk.
      • According to this "erratum" note in a medical journal, many patients who are scheduled for surgery experience remission before the surgery is actually performed.   The authors suggest scheduling surgery two months in advance, possibly not in earnest, to see whether simply scheduling the surgery will produce remission.
    • Tubes.
      • Pressure equalization (PE) tubes, tympanostomy tubes, myringotomy tubes, ventilation tubes, and grommets.
      • The middle ear is "ventilated" by virtue of a structure called the Eustachian tube. This tube connects the middle ear to the pharynx (throat). It is like a valve that opens and closes. When it opens, air pressure in the middle ear is equalized with the outside air pressure. The Eustacian tube typically opens during yawning and swallowing.  The the function of the Eustacian tube, and the state of air pressure in the middle ear, can be tested by means of a tympanogram.
      • If the Eustachian tube is becomes dysfunctional by blockage due to congestion, infection or otherwise, air pressure in the middle ear can occur to the point of pain.  Congestion and infection may be treated by decongestants, antihistamines, and antibiotics (if the infection is suspected to be bacterial in nature).
      • For chronic (continuing) cases, doctors sometimes create an alternate opening to middle ear from the outer ear by creating an opening in the eardrum and by inserting a tube called a "pressure equalization (PE) tube" or a "ventilation tube" or, sometimes (especially in Australia), a "grommet." ("Pressure equalization" means "air pressure equalization.")  When a PE tube is in place, there is a continuous opening in the eardrum, and air pressure in the middle ear is continuously "equalized" with the air pressure outside of the middle ear. Infants suffering from middle ear infections (otitis media) often have PE tubes inserted.
      • The symptom of fullness that is experienced with Meniere's Disease feels just like air pressure in the middle ear -- but it is *not* air pressure in the middle ear. Meniere's Disease does not affect the middle ear.  Meniere's Disease has nothing to do with the Eustachian tube, and the typical Meniere's Disease patient has a fully functioning Eustachian tube. If so, adding a PE tube wouldn't seem to accomplish anything. Nonetheless, doctors sometimes insert PE tubes into patients who have fully functional Eustachian tubes, and the patients sometimes report improvement with their symptoms, possibly (or probably) due to a placebo effect.
      • Click here to read Dr. Timothy Hain's comments on PE tubes.
      • Click here to search PubMed for Meniere's Disease and pressure equalization (PE) tubes (also called ventilation tubes and grommets).
    • Intratympanic instillation and perfusion of drugs.
      • Also called transtympanic instillation and perfusion of drugs.
      • Intratympanic (through the tympanic membrane (ear drum)) instillation (insertion) and perfusion ("seeping" through the round window separating the middle ear from the inner ear) of various drugs, including dexamethasone (DMZ) (Decadron), streptomycin, and gentamicin).
      • Note:  The October 2004 issue (Vol. 27, pp. 955-1113) of "Otolaryngologic Clinics of North America" is devoted to "Intratympanics (sic) Treatment of Inner Ear Disease."  The titles of the 10 substantive articles inside appear relevant and interesting to Meniere's Disease patients.  Click here to view the contents.  Viewing the full text is trickier. There is a 30 day trial, there is access to individual articles, and there is access to purchasing a full issue. A more practical means of access is to visit a hospital or medical school library.  (See our research page.)
      • Graphic (click to enlarge).  


      Click to Enlarge
       

      • Drugs used in intratympanic instillation and perfusion.
        • Nonototoxic drugs. 
          • Some corticosteroid drugs are used, perhaps among other purposes, to (1) reduce inflammation and (2) to suppress the immune system.
          • Dexamethasone (DMZ) (Decadron).
            • The apparent purpose of intratympanic instillation and perfusion of DMZ is to reduce inflammation and to suppress the immune system very directly, perhaps together with or followed by additional DMZ administered intravenously and/or orally. Apparently, this therapy presumes that inflammation and/or an autoimmune (overactive immune) condition is causing or contributing to the symptoms. DMZ is apparently not believed to be ototoxic. Some physicians believe that this procedure has great potential for relieving vertigo while preserving, and in some cases, even improving hearing. Others disagree. As always, see your physician for medical advice.
            • Click here to search PubMed for Meniere's Disease and Dexamethasone (DMZ) (decadron).
            • August 10, 2005 -- A study on the use of intratrympanic dexamethasone to treat Meniere's Disease has been added to PubMed:  Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere's disease: a two-year prospective, placebo-controlled, double-blind, randomized trialThe abstract names the affiliation of the authors as "National Institute of Neurology and Neurosurgery," which we presume refers to the institute by that name that is located in Mexico City. According to the abstract, in the experimental group of 11 patients who received injections of dexamethasone, nine patients achieved "complete control of vertigo," and the remaining two patients achieved "substantial control of vertigo" over two years. In the control group of 11 patients who received injections of a saline solution placebo, four of the patients achieved "complete control of vertigo," none achieved "substantial control of vertigo," three patients achieved lesser control of vertigo, and four patients were classified as treatment failures and went on to receive other treatment before the end of the two-year period.  Patients in the experimental group reported subjective improvements in the symptoms of tinnitus, aural fullness, and hearing loss, to a greater extent than did patients in the control group.
          • Labyrinth anesthesia (lidocaine).
            • From time to time, researchers will instill lidocaine (sometimes together with the drug Kinetin) into the middle ear (for subsequent perfusion into the inner ear) in hopes of improving Meniere's Disease symptoms.  Just how this might work has not been satisfactorily explained (at least, not to us).  Note that this is a topic distinct from the use of lidocaine in treating tinnitus (from Meniere's Disease or otherwise), above.
        • Ototoxic drugs ("ear poisons").
        •  
          • The purpose of intratympanic instillation and perfusion of ototoxic drugs ("ear poisons") is to chemically ablate (destroy) part or all of the inner ear.
            • Streptomycin ("strep").
              • The famous antibiotic streptomycin is very ototoxic, which is one reason why it is no longer used as an antibiotic, except in rare cases when there is no other treatment. Not only is streptomycin toxic to the vestibule (balance function), but it is also toxic to the cochlea (hearing function). Streptomycin may be used to chemically ablate the balance function, but it will also destroy whatever may be left of the hearing function, thus resulting in a "chemical labyrinthectomy" (in effect, destruction of the entire labyrinth).  An alternative would be a "surgical" labyrinthectomy, in which the organs of the labyrinth are surgically removed. A high dose of gentamicin (see below) could be used instead of streptomycin. Streptomycin may be administered intravenously to accomplish the same result, but the destruction that results from this procedure applies to both ears instead of one ear.  This methodology is usually used, if at all, only when the patient is bilateral (Meniere's Disease symptoms in both ears) and has already lost all, or nearly all, hearing in both ears.
              • Click here to search PubMed for Meniere's Disease and streptomycin.
            • Gentamicin ("gent").
              • Like streptomycin (above), gentamicin is an antibiotic, and it is also ototoxic, although less ototoxic than streptomycin.
              • There are three possible reasons for intratympanic instillation of gentamicin.
                • 1. To destroy the "dark cells" that produce endolymph, with the objective of reducing the production of endolymph, thus reducing the "hydrops." If this is the reason, the hope is that the tiny hairs in the vestibule (which affect the balance function) and the tiny hairs in the cochlea (which affect the hearing function) will be undamaged, or at least not damaged very much. This is usually a very low dose (in terms of volume and strength) of gentamicin. There may be one or more injections, and the length of time (interval) between multiple injections may vary.
                • 2. To damage the tiny hairs in the vestibule with the objective of impairing the transmission of faulty vestibular (balance) data to the brain. If this is the reason, the hope is that the tiny hairs in the cochlea will be undamaged, or at least not damaged much, because damage to the tiny hairs in the cochlea causes hearing loss. There may be one or more injections, and the length of time between multiple injections may vary. This is usually a somewhat higher dose of gentamicin that is given for purpose 1 above, but still a low enough dose to attempt to preserve whatever hearing may remain.
                • 3. To ablate (destroy) the labyrinth totally, using a high dose of gentamicin, with the objective of totally destroying the tiny hairs in the vestibule to block all transmission of vestibular (balance) data to the brain, and accepting the concurrent destruction of the tiny hairs in the cochlea, which will cause deafness. This high dose of gentamicin is usually (but not always) performed when there is little or no functional hearing left. This is called a "chemical labyrinthectomy," because the effect is to totally destroy all functions of the labyrinth, both vestibular and cochlear. Streptomycin (see above) could be used for this purpose instead of gentamicin.  An alternative would be a "surgical" labyrinthectomy, in which the organs of the labyrinth are surgically removed.
              • There are different "protocols" for each of the  methodologies above, depending on the patient and on the doctor. The strength of the gentamicin and the interval between the instillations may vary.
              • University of Pittsburgh Medical Center.
              • Click here to search PubMed for Meniere's Disease and gentamicin/gentamycin.
              • August 25, 2005 -- A study on the use of intratympanic gentamicin to treat Meniere's Disease has been added to PubMed:  Long-term results of the transtympanic (intratympanic) gentamicin treatment in Meniere's disease.  The affiliation of the authors is the Clinic of Otolaryngology in Warsaw, and the article is in Polish.  According to the abstract, nine patients were followed for 24 months, of whom all nine achieved complete control of vertigo, while hearing was improved in six patients, unchanged in two patients, and profoundly lost in "only" one patient.
                • Comment:  We believe that "only" one out of nine patients deafened represents a serious risk.  It seems to us that key to the outcome of intratympanic gentamicin treatment is the protocol used:  the strength of the gentamicin, the quantity instilled, and the interval between instillations.  We believe that a good analysis of such studies can only be made having the specific protocols at hand. We recommend that a patient considering intratympanic gentamicin treatment ask one's doctor for the protocol contemplated and for the studies using that protocol upon which that doctor is relying in selecting it.  (Then sit back in your chair and watch the reaction.)
      • Methodology.
        • Simple.
          • In the simplest of methods, an office procedure, one lies on one's side, with the ear to be treated toward the sky and the other ear against the bed or whatever surface one is lying upon.  A surgeon swabs the ear drum with a local anesthetic, then pokes a needle through the ear drum and instills (injects with a syringe) a drug toward the round window.  [Note:  the source of this methodology is anecdotal reports from patients.]  The patient lies still for some period of time, and with luck the drug will pool in the round window and perfuse through the round window to the inner ear.  The procedure may be repeated every week or every few weeks for a few administrations.
        • Laser.
          • With this method, performed in an office, surgical suite, or hospital, one lies on one's side, with the ear to be treated toward the sky and the other ear against the bed or whatever surface one is lying upon.  The patient is either placed under general anesthesia or the ear drum is swabbed with a local anesthesia.  The surgeon then uses a laser to burn a hole through the ear drum.  (Note that the laser is not used to "treat" Meniere's Disease; the laser is merely a tool to place a hole in the eardrum.)  A drug is then instilled (injected with a syringe) toward the round window.  The patient lies still for some period of time, and with luck the drug will pool in the round window and perfuse through the round window to the inner ear.  The patient lies for a couple of hours or so in a recovery room in the position described above.  The hole in the eardrum heals over a couple of weeks.  This method might involve daily administration of the drug for a few days.
        • Gelfoam (absorbable gelatin sponge)
        •  
        • Silverstein MicroWick
        • .
        • Round Window Microcatheter (also:  Round Window Micro-Catheter).
          • The Round Window Microcatheter is a portable pump used to deliver a consistent, controlled,  quantity of low-potency gentamicin through the ear drum to the round window membrane separating the middle ear from the inner ear, with the intention that the gentamicin perfuse through the round window membrane to the inner ear.  The intention is that a controlled delivery of low-potency gentamicin over weeks would permit the destruction of cells in the inner ear in order to reduce vertigo, yet at the same time not be so destructive as to further impair hearing.  We first read about the round window microcatheter in this 1997 U.S. Navy press release, which describes its use by Navy doctors at the Naval Medical Center in San Diego. At the time, the device was manufactured and marketed by a company called "IntraEar, Inc."  In 2001, Durect, Inc., acquired IntraEar, Inc., and the round window microcatheter  As of